Table of Content

1 Anti Obesity Drugs Market Overview
1.1 Anti Obesity Drugs Product Overview
1.2 Anti Obesity Drugs Market Segment by Type
1.2.1 Oral Medicine
1.2.2 Diet Patch
1.2.3 Other
1.3 Global Anti Obesity Drugs Market Size by Type
1.3.1 Global Anti Obesity Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Anti Obesity Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti Obesity Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti Obesity Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti Obesity Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti Obesity Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti Obesity Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti Obesity Drugs Sales Breakdown by Type (2018-2024)
2 Global Anti Obesity Drugs Market Competition by Company
2.1 Global Top Players by Anti Obesity Drugs Sales (2018-2024)
2.2 Global Top Players by Anti Obesity Drugs Revenue (2018-2024)
2.3 Global Top Players by Anti Obesity Drugs Price (2018-2024)
2.4 Global Top Manufacturers Anti Obesity Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti Obesity Drugs Market Competitive Situation and Trends
2.5.1 Anti Obesity Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti Obesity Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti Obesity Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anti Obesity Drugs Market
2.8 Key Manufacturers Anti Obesity Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti Obesity Drugs Status and Outlook by Region
3.1 Global Anti Obesity Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anti Obesity Drugs Historic Market Size by Region
3.2.1 Global Anti Obesity Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Anti Obesity Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Anti Obesity Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti Obesity Drugs Forecasted Market Size by Region
3.3.1 Global Anti Obesity Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Anti Obesity Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Anti Obesity Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti Obesity Drugs by Application
4.1 Anti Obesity Drugs Market Segment by Application
4.1.1 Men
4.1.2 Women
4.2 Global Anti Obesity Drugs Market Size by Application
4.2.1 Global Anti Obesity Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Anti Obesity Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anti Obesity Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti Obesity Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anti Obesity Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anti Obesity Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anti Obesity Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anti Obesity Drugs Sales Breakdown by Application (2018-2024)
5 North America Anti Obesity Drugs by Country
5.1 North America Anti Obesity Drugs Historic Market Size by Country
5.1.1 North America Anti Obesity Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anti Obesity Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Anti Obesity Drugs Sales in Value by Country (2018-2024)
5.2 North America Anti Obesity Drugs Forecasted Market Size by Country
5.2.1 North America Anti Obesity Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Anti Obesity Drugs Sales in Value by Country (2024-2034)
6 Europe Anti Obesity Drugs by Country
6.1 Europe Anti Obesity Drugs Historic Market Size by Country
6.1.1 Europe Anti Obesity Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anti Obesity Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti Obesity Drugs Sales in Value by Country (2018-2024)
6.2 Europe Anti Obesity Drugs Forecasted Market Size by Country
6.2.1 Europe Anti Obesity Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti Obesity Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti Obesity Drugs by Region
7.1 Asia-Pacific Anti Obesity Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti Obesity Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti Obesity Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti Obesity Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti Obesity Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti Obesity Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti Obesity Drugs Sales in Value by Region (2024-2034)
8 Latin America Anti Obesity Drugs by Country
8.1 Latin America Anti Obesity Drugs Historic Market Size by Country
8.1.1 Latin America Anti Obesity Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anti Obesity Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti Obesity Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Anti Obesity Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti Obesity Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti Obesity Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti Obesity Drugs by Country
9.1 Middle East and Africa Anti Obesity Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti Obesity Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti Obesity Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti Obesity Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti Obesity Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti Obesity Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti Obesity Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Anti Obesity Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck Anti Obesity Drugs Products Offered
10.2.5 Merck Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roche Anti Obesity Drugs Products Offered
10.3.5 Roche Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Information
10.4.2 GlaxoSmithKline Introduction and Business Overview
10.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 GlaxoSmithKline Anti Obesity Drugs Products Offered
10.4.5 GlaxoSmithKline Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca Anti Obesity Drugs Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Boehringer Ingelheim Anti Obesity Drugs Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Novo Nordisk
10.7.1 Novo Nordisk Company Information
10.7.2 Novo Nordisk Introduction and Business Overview
10.7.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Novo Nordisk Anti Obesity Drugs Products Offered
10.7.5 Novo Nordisk Recent Development
10.8 Eisai
10.8.1 Eisai Company Information
10.8.2 Eisai Introduction and Business Overview
10.8.3 Eisai Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Eisai Anti Obesity Drugs Products Offered
10.8.5 Eisai Recent Development
10.9 Norgine
10.9.1 Norgine Company Information
10.9.2 Norgine Introduction and Business Overview
10.9.3 Norgine Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Norgine Anti Obesity Drugs Products Offered
10.9.5 Norgine Recent Development
10.10 Arena Pharmaceuticals
10.10.1 Arena Pharmaceuticals Company Information
10.10.2 Arena Pharmaceuticals Introduction and Business Overview
10.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Arena Pharmaceuticals Anti Obesity Drugs Products Offered
10.10.5 Arena Pharmaceuticals Recent Development
10.11 Orexigen Therapeutics
10.11.1 Orexigen Therapeutics Company Information
10.11.2 Orexigen Therapeutics Introduction and Business Overview
10.11.3 Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Orexigen Therapeutics Anti Obesity Drugs Products Offered
10.11.5 Orexigen Therapeutics Recent Development
10.12 Vivus
10.12.1 Vivus Company Information
10.12.2 Vivus Introduction and Business Overview
10.12.3 Vivus Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Vivus Anti Obesity Drugs Products Offered
10.12.5 Vivus Recent Development
10.13 Alizyme
10.13.1 Alizyme Company Information
10.13.2 Alizyme Introduction and Business Overview
10.13.3 Alizyme Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Alizyme Anti Obesity Drugs Products Offered
10.13.5 Alizyme Recent Development
10.14 Rhythm Pharmaceuticals
10.14.1 Rhythm Pharmaceuticals Company Information
10.14.2 Rhythm Pharmaceuticals Introduction and Business Overview
10.14.3 Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Rhythm Pharmaceuticals Anti Obesity Drugs Products Offered
10.14.5 Rhythm Pharmaceuticals Recent Development
10.15 Shionogi
10.15.1 Shionogi Company Information
10.15.2 Shionogi Introduction and Business Overview
10.15.3 Shionogi Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shionogi Anti Obesity Drugs Products Offered
10.15.5 Shionogi Recent Development
10.16 Zafgan
10.16.1 Zafgan Company Information
10.16.2 Zafgan Introduction and Business Overview
10.16.3 Zafgan Anti Obesity Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Zafgan Anti Obesity Drugs Products Offered
10.16.5 Zafgan Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti Obesity Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti Obesity Drugs Industrial Chain Analysis
11.4 Anti Obesity Drugs Market Dynamics
11.4.1 Anti Obesity Drugs Industry Trends
11.4.2 Anti Obesity Drugs Market Drivers
11.4.3 Anti Obesity Drugs Market Challenges
11.4.4 Anti Obesity Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti Obesity Drugs Distributors
12.3 Anti Obesity Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oral Medicine
Table 2. Major Company of Diet Patch
Table 3. Major Company of Other
Table 4. Global Anti Obesity Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Anti Obesity Drugs Sales by Type (2018-2024) & (K Units)
Table 6. Global Anti Obesity Drugs Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Anti Obesity Drugs Sales by Type (2018-2024) & (US& Million)
Table 8. Global Anti Obesity Drugs Market Share in Value by Type (2018-2024)
Table 9. Global Anti Obesity Drugs Price by Type (2018-2024) & (USD/Units)
Table 10. Global Anti Obesity Drugs Sales by Type (2024-2034) & (K Units)
Table 11. Global Anti Obesity Drugs Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Anti Obesity Drugs Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Anti Obesity Drugs Sales Market Share in Value by Type (2024-2034)
Table 14. Global Anti Obesity Drugs Price by Type (2024-2034) & (USD/Units)
Table 15. North America Anti Obesity Drugs Sales by Type (2018-2024) & (K Units)
Table 16. North America Anti Obesity Drugs Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Anti Obesity Drugs Sales (K Units) by Type (2018-2024)
Table 18. Europe Anti Obesity Drugs Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Anti Obesity Drugs Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Anti Obesity Drugs Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Anti Obesity Drugs Sales (K Units) by Type (2018-2024)
Table 22. Latin America Anti Obesity Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Anti Obesity Drugs Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Anti Obesity Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Anti Obesity Drugs Sales by Company (2018-2024) & (K Units)
Table 26. Global Anti Obesity Drugs Sales Share by Company (2018-2024)
Table 27. Global Anti Obesity Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Anti Obesity Drugs Revenue Share by Company (2018-2024)
Table 29. Global Market Anti Obesity Drugs Price by Company (2018-2024) & (USD/Units)
Table 30. Global Anti Obesity Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Anti Obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti Obesity Drugs as of 2022)
Table 33. Date of Key Manufacturers Enter into Anti Obesity Drugs Market
Table 34. Key Manufacturers Anti Obesity Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Anti Obesity Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Anti Obesity Drugs Sales by Region (2018-2024) & (K Units)
Table 38. Global Anti Obesity Drugs Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Anti Obesity Drugs Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Anti Obesity Drugs Sales Market Share in Value by Region (2018-2024)
Table 41. Global Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2018-2024)
Table 42. Global Anti Obesity Drugs Sales by Region (2024-2034) & (K Units)
Table 43. Global Anti Obesity Drugs Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Anti Obesity Drugs Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Anti Obesity Drugs Sales Market Share in Value by Region (2024-2034)
Table 46. Global Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2024-2034)
Table 47. Global Anti Obesity Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Anti Obesity Drugs Sales by Application (2018-2024) & (K Units)
Table 49. Global Anti Obesity Drugs Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Anti Obesity Drugs Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Anti Obesity Drugs Sales Market Share in Value by Application (2018-2024)
Table 52. Global Anti Obesity Drugs Price by Application (2018-2024) & (USD/Units)
Table 53. Global Anti Obesity Drugs Sales by Application (2024-2034) & (K Units)
Table 54. Global Anti Obesity Drugs Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Anti Obesity Drugs Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Anti Obesity Drugs Sales Market Share in Value by Application (2024-2034)
Table 57. Global Anti Obesity Drugs Price by Application (2024-2034) & (USD/Units)
Table 58. North America Anti Obesity Drugs Sales by Application (2018-2024) (K Units)
Table 59. North America Anti Obesity Drugs Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Anti Obesity Drugs Sales by Application (2018-2024) (K Units)
Table 61. Europe Anti Obesity Drugs Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Anti Obesity Drugs Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Anti Obesity Drugs Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Anti Obesity Drugs Sales by Application (2018-2024) (K Units)
Table 65. Latin America Anti Obesity Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Anti Obesity Drugs Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Anti Obesity Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Anti Obesity Drugs Sales by Country (2018-2024) & (K Units)
Table 69. North America Anti Obesity Drugs Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Anti Obesity Drugs Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Anti Obesity Drugs Sales Market Share in Value by Country (2018-2024)
Table 72. North America Anti Obesity Drugs Sales by Country (2024-2034) & (K Units)
Table 73. North America Anti Obesity Drugs Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Anti Obesity Drugs Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Anti Obesity Drugs Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Anti Obesity Drugs Sales by Country (2018-2024) & (K Units)
Table 77. Europe Anti Obesity Drugs Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Anti Obesity Drugs Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Anti Obesity Drugs Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Anti Obesity Drugs Sales by Country (2024-2034) & (K Units)
Table 81. Europe Anti Obesity Drugs Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Anti Obesity Drugs Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Anti Obesity Drugs Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Anti Obesity Drugs Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Anti Obesity Drugs Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Anti Obesity Drugs Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Anti Obesity Drugs Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Anti Obesity Drugs Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Anti Obesity Drugs Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Anti Obesity Drugs Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Anti Obesity Drugs Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Anti Obesity Drugs Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Anti Obesity Drugs Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Anti Obesity Drugs Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Anti Obesity Drugs Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Anti Obesity Drugs Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Anti Obesity Drugs Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Anti Obesity Drugs Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Anti Obesity Drugs Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Anti Obesity Drugs Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Anti Obesity Drugs Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Anti Obesity Drugs Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Anti Obesity Drugs Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Anti Obesity Drugs Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Anti Obesity Drugs Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Anti Obesity Drugs Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Anti Obesity Drugs Sales Market Share in Value by Country (2024-2034)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 111. Pfizer Anti Obesity Drugs Product
Table 112. Pfizer Recent Development
Table 113. Merck Company Information
Table 114. Merck Introduction and Business Overview
Table 115. Merck Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 116. Merck Anti Obesity Drugs Product
Table 117. Merck Recent Development
Table 118. Roche Company Information
Table 119. Roche Introduction and Business Overview
Table 120. Roche Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 121. Roche Anti Obesity Drugs Product
Table 122. Roche Recent Development
Table 123. GlaxoSmithKline Company Information
Table 124. GlaxoSmithKline Introduction and Business Overview
Table 125. GlaxoSmithKline Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 126. GlaxoSmithKline Anti Obesity Drugs Product
Table 127. GlaxoSmithKline Recent Development
Table 128. AstraZeneca Company Information
Table 129. AstraZeneca Introduction and Business Overview
Table 130. AstraZeneca Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 131. AstraZeneca Anti Obesity Drugs Product
Table 132. AstraZeneca Recent Development
Table 133. Boehringer Ingelheim Company Information
Table 134. Boehringer Ingelheim Introduction and Business Overview
Table 135. Boehringer Ingelheim Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 136. Boehringer Ingelheim Anti Obesity Drugs Product
Table 137. Boehringer Ingelheim Recent Development
Table 138. Novo Nordisk Company Information
Table 139. Novo Nordisk Introduction and Business Overview
Table 140. Novo Nordisk Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 141. Novo Nordisk Anti Obesity Drugs Product
Table 142. Novo Nordisk Recent Development
Table 143. Eisai Company Information
Table 144. Eisai Introduction and Business Overview
Table 145. Eisai Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 146. Eisai Anti Obesity Drugs Product
Table 147. Eisai Recent Development
Table 148. Norgine Company Information
Table 149. Norgine Introduction and Business Overview
Table 150. Norgine Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 151. Norgine Anti Obesity Drugs Product
Table 152. Norgine Recent Development
Table 153. Arena Pharmaceuticals Company Information
Table 154. Arena Pharmaceuticals Introduction and Business Overview
Table 155. Arena Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 156. Arena Pharmaceuticals Anti Obesity Drugs Product
Table 157. Arena Pharmaceuticals Recent Development
Table 158. Orexigen Therapeutics Company Information
Table 159. Orexigen Therapeutics Introduction and Business Overview
Table 160. Orexigen Therapeutics Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 161. Orexigen Therapeutics Anti Obesity Drugs Product
Table 162. Orexigen Therapeutics Recent Development
Table 163. Vivus Company Information
Table 164. Vivus Introduction and Business Overview
Table 165. Vivus Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 166. Vivus Anti Obesity Drugs Product
Table 167. Vivus Recent Development
Table 168. Alizyme Company Information
Table 169. Alizyme Introduction and Business Overview
Table 170. Alizyme Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 171. Alizyme Anti Obesity Drugs Product
Table 172. Alizyme Recent Development
Table 173. Rhythm Pharmaceuticals Company Information
Table 174. Rhythm Pharmaceuticals Introduction and Business Overview
Table 175. Rhythm Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 176. Rhythm Pharmaceuticals Anti Obesity Drugs Product
Table 177. Rhythm Pharmaceuticals Recent Development
Table 178. Shionogi Company Information
Table 179. Shionogi Introduction and Business Overview
Table 180. Shionogi Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 181. Shionogi Anti Obesity Drugs Product
Table 182. Shionogi Recent Development
Table 183. Zafgan Company Information
Table 184. Zafgan Introduction and Business Overview
Table 185. Zafgan Anti Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 186. Zafgan Anti Obesity Drugs Product
Table 187. Zafgan Recent Development
Table 188. Key Raw Materials Lists
Table 189. Raw Materials Key Suppliers Lists
Table 190. Anti Obesity Drugs Market Trends
Table 191. Anti Obesity Drugs Market Drivers
Table 192. Anti Obesity Drugs Market Challenges
Table 193. Anti Obesity Drugs Market Restraints
Table 194. Anti Obesity Drugs Distributors List
Table 195. Anti Obesity Drugs Downstream Customers
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti Obesity Drugs Product Picture
Figure 2. Global Anti Obesity Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti Obesity Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anti Obesity Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Oral Medicine
Figure 6. Global Oral Medicine Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Diet Patch
Figure 8. Global Diet Patch Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Other
Figure 10. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Anti Obesity Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Anti Obesity Drugs Sales Market Share by Type in 2022 & 2034
Figure 13. North America Anti Obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 14. North America Anti Obesity Drugs Sales Market Share in Value by Type in 2022
Figure 15. Europe Anti Obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Europe Anti Obesity Drugs Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Anti Obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Anti Obesity Drugs Sales Market Share in Value by Type in 2022
Figure 19. Latin America Anti Obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Anti Obesity Drugs Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Anti Obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Anti Obesity Drugs Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti Obesity Drugs Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti Obesity Drugs Revenue in 2022
Figure 25. Anti Obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Men
Figure 27. Global Men Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Women
Figure 29. Global Women Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Anti Obesity Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Anti Obesity Drugs Sales Market Share by Application in 2022 & 2034
Figure 32. North America Anti Obesity Drugs Sales Market Share in Volume by Application in 2022
Figure 33. North America Anti Obesity Drugs Sales Market Share in Value by Application in 2022
Figure 34. Europe Anti Obesity Drugs Sales Market Share in Volume by Application in 2022
Figure 35. Europe Anti Obesity Drugs Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Anti Obesity Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Anti Obesity Drugs Sales Market Share in Value by Application in 2022
Figure 38. Latin America Anti Obesity Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Anti Obesity Drugs Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Anti Obesity Drugs Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Anti Obesity Drugs Manufacturing Cost Structure
Figure 43. Anti Obesity Drugs Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed